Alphabet's Verily Is Getting Deeper Into Diabetes Management
A new venture aims to help people control their disease—and change behavior in ways that will help keep the disease from controlling them.
A new venture aims to help people control their disease—and change behavior in ways that will help keep the disease from controlling them.
Verily, Alphabet's life sciences group, is investing big in developing technologies for the millions of people worldwide with diabetes.
No comments have been added yet.
David Lidsky's Blog
- David Lidsky's profile
- 3 followers
David Lidsky isn't a Goodreads Author
(yet),
but they
do have a blog,
so here are some recent posts imported from
their feed.
